The Hermia Theranostics is a very promising personalized approach to treating cancer, using diagnostic imaging to identify if target receptors are present on cancer cells, followed by precision internal radiation treatment that targets these receptors. This approach is, today, mostly used in metastatic prostate cancer, liver cancer and neuroendocrine tumors.
Please select your region: